All content for The Interventional Glaucoma Podcast is the property of Bausch + Lomb Elios and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of the Interventional Glaucoma Podcast, Prof. Gus Gazzard is joined by Prof. Cédric Schweitzer and Dr. Marc Töteberg-Harms to explore what the data tell us about interventional glaucoma. They discuss the robustness of Elios peer-reviewed evidence on efficacy, safety, and long-term outcomes, the crucial role of high-quality data in guiding everyday clinical decisions, and the continued commitment to ongoing research and future data collection in glaucoma care.
The ELIOS system (Bausch & Lomb) is manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17, Germany and by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked for use in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). The ExTra II (laser class 4) has the brand name ELIOS. The ExTra II is equivalent to ExTra and AIDA devices.
Find out more about ELIOS : http://bit.ly/4lWBJZ1
